Multiple Myeloma Journalists' Workshop Webcast
The International Myeloma Foundation (IMF), with Myeloma Canada, sponsored a Journalists' Workshop Thursday evening (June 13) at EHA 2013 (European Hematology Association Annual Meeting) to discuss and analyze the very latest treatments for multiple myeloma, and how advancements will affect patient treatment.

Myeloma is the second most prevalent blood cancer, and although it cannot be cured, new treatment regimens are providing many patients with long-term remissions and a good quality of life. Below you can choose to view the webcast in one of four different languages.